MYCN and neuroblastoma: Multivariate survival analyses on two neuroblastoma cohorts (Kocak GSE45547; SEQC GSE62564) that incorporated MYCN amplification, patient age and tumor stage as other prognostic variables, indicated that high ATP13A3 expression is an independent prognostic marker for neuroblastoma outcome (Table 1).